RICHMOND, VA. – BRAINBox Solutions today announced that the company has enrolled the 1,000 th patient in the pivotal, HeadSMART II study of its concussion diagnostic and prognostic test, BRAINBox TBI. The multi-national, multi-site, trial is designed to support an application for regulatory clearance by the U.S.